All News


Products derived from embryonic stem cells are not patentable

Therapies based on human embryonic stem cells should not be granted patents, according to the latest opinion from the Court of Justice of the European Union. If confirmed, this will have a major impact on stem cell research in Europe and on the European life sciences industry as a whole

The difficulties of energy R&D

Memo to governments: Energy research is different than that in other sectors – longer term, more costly, higher hurdles to market.